Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, USA.
J Am Coll Cardiol. 2012 Jan 10;59(2):97-104. doi: 10.1016/j.jacc.2011.09.044.
With a prevalence of 5.8 million in the United States alone, heart failure (HF) is a common syndrome associated with substantial morbidity, mortality, and healthcare expenditures. Close to 1 million HF hospitalizations occur annually in the United States, with the majority of these resulting from worsening congestion in patients previously diagnosed with HF. An estimated $37.2 billion is spent each year on HF in the United States. These statistics emphasize the need to develop and implement more effective strategies to assess, monitor, and treat HF. It has also become increasingly apparent that interventions geared toward identifying and monitoring subclinical congestion would be of value in the home management of chronic HF. Earlier identification and treatment of congestion together with improved care coordination, management of comorbid conditions, and enhanced patient self-management may help to prevent hospitalizations in patients with chronic HF. Such home monitoring extends from the promotion of self-care and home visitations to telemedicine and remote monitoring of external or implantable devices. This paper discusses the challenges in monitoring patients with HF, reviews clinical trials testing different monitoring strategies in HF, and highlights ongoing investigations into the optimal approaches to home monitoring for HF.
仅在美国,心力衰竭(HF)的患病率就高达 580 万,是一种与大量发病率、死亡率和医疗支出相关的常见综合征。美国每年约有 100 万例心力衰竭住院,其中大多数是由于先前诊断为心力衰竭的患者充血恶化所致。在美国,每年用于心力衰竭的费用估计为 372 亿美元。这些统计数据强调了需要制定和实施更有效的策略来评估、监测和治疗心力衰竭。越来越明显的是,针对识别和监测亚临床充血的干预措施将对慢性心力衰竭的家庭管理具有重要价值。早期识别和治疗充血以及改善护理协调、合并症管理和增强患者自我管理能力,可能有助于预防慢性心力衰竭患者的住院治疗。这种家庭监测不仅包括促进自我护理和家访,还包括远程医疗和外部或植入设备的远程监测。本文讨论了监测心力衰竭患者的挑战,回顾了心力衰竭不同监测策略的临床试验,并强调了正在进行的关于心力衰竭家庭监测最佳方法的研究。